Our family of portfolio
companies is involved in sectors of industry ranging from networking to
software to life sciences. Click on a link below to learn more
about any of the companies in our portfolio.
Networks (sold to EMC)
Networks is the leader in network-management-software solutions for
storage, server, and system area networks.
(became public in 2005)
Lpath is a developer of a novel platform technology for the
diagnosis and treatment of various cancers as well as inflammatory
diseases and heart disease. They are the first company ever to produce a monoclonal
antibody to a lysolipid; this antibody has shown compelling
results against severe forms of human cancer in mouse models.
Pharmaceuticals (sold to Axcan)
Mpex Pharmaceuticals is focused on the discovery and
development of new antibiotics that meet the growing clinical need created
by multi-drug resistant bacterial pathogens.
Neology (sold to Smartrac)
Neology is a maker of highly functional, yet low-cost, RFID tags
with a wide variety of applications. Neology's primary focus
currently is in the security and life sciences sectors.
(sold to Medtronic)
a developer of two novel endoscopic technologies, one diagnostic and
one therapeutic, that will have a significant impact on the gastroenterologist's
ability to manage patients with gastro esophageal reflux
a procedure for non-invasively detecting biological markers in skin
cells. This procedure has wide-ranging applications in diagnostics,
pharmacogenomics, and functional genomics.
(sold to Balboa)
a manufacturer of patented water-treatment devices and sensor
technologies for use in spa, pool, fountain, and cooling-tower
has developed a novel vaccine delivery platform that has applications across a wide
range of diseases.